Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NVS

Novartis AG ADR

Jul 26 • 04:00PM ET

110.32

Dollar change +0.39
Percentage change 0.35	%

Healthcare • Drug Manufacturers - General • Switzerland • NYSE

Stock Detail • Compare Perf. • Financials • Options Chain • Save to Portfolio • Create Alert

Held by: DFIV DFAI DFIC FVD AVDE GCOW DFAX PPH PID DIHP

Scroll to Statements

Index	-	P/E	14.06	EPS (ttm)	7.85	Insider Own	0.00%	Shs Outstand	2.04B	Perf Week	3.95%
Market Cap	215.84B	Forward P/E	13.64	EPS next Y	8.09	Insider Trans	-	Shs Float	1.96B	Perf Month	3.04%
Income	16.18B	PEG	1.95	EPS next Q	1.88	Inst Own	7.28%	Short Float	0.32%	Perf Quarter	11.37%
Sales	47.55B	P/S	4.54	EPS this Y	14.40%	Inst Trans	-9.12%	Short Ratio	4.50	Perf Half Y	3.11%
Book/sh	20.61	P/B	5.35	EPS next Y	9.25%	ROA	9.67%	Short Interest	6.23M	Perf Year	12.22%
Cash/sh	4.31	P/C	25.59	EPS next 5Y	7.21%	ROE	21.55%	52W Range	91.70 - 112.48	Perf YTD	9.26%
Dividend Est.	3.80 (3.44%)	P/FCF	15.36	EPS past 5Y	5.63%	ROI	25.69%	52W High	-1.92%	Beta	0.57
Dividend TTM	3.74 (3.39%)	Quick Ratio	0.72	Sales past 5Y	0.78%	Gross Margin	73.29%	52W Low	20.30%	ATR (14)	1.59
Dividend Ex-Date	Mar 07, 2024	Current Ratio	0.93	EPS Y/Y TTM	118.83%	Oper. Margin	28.88%	RSI (14)	58.62	Volatility	1.08% 1.02%
Employees	76057	Debt/Eq	0.69	Sales Y/Y TTM	-8.23%	Profit Margin	34.02%	Recom	2.46	Target Price	116.88
Option/Short	Yes / Yes	LT Debt/Eq	0.51	EPS Q/Q	43.51%	Payout	44.73%	Rel Volume	0.62	Prev Close	109.93
Sales Surprise	1.15%	EPS Surprise	6.46%	Sales Q/Q	-8.15%	Earnings	Jul 18 BMO	Avg Volume	1.38M	Price	110.32
SMA20	1.63%	SMA50	4.29%	SMA200	9.63%	Trades		Volume	858,846	Change	0.35%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-19-24	Downgrade	Deutsche Bank	Buy → Hold
May-30-24	Initiated	Goldman	Buy	$120
Feb-23-24	Initiated	BMO Capital Markets	Market Perform	$114
Jan-23-24	Initiated	Morgan Stanley	Equal-Weight	$114
Jan-16-24	Resumed	UBS	Buy
Dec-18-23	Downgrade	HSBC Securities	Buy → Hold
Sep-25-23	Upgrade	Morgan Stanley	Underweight → Equal-Weight
Jul-14-23	Initiated	HSBC Securities	Buy
Apr-26-23	Upgrade	Deutsche Bank	Hold → Buy
Mar-27-23	Upgrade	Deutsche Bank	Sell → Hold
Jan-26-23	Downgrade	Citigroup	Buy → Neutral
Dec-05-22	Upgrade	Stifel	Hold → Buy
Sep-15-22	Downgrade	Credit Suisse	Neutral → Underperform
Sep-14-22	Downgrade	Berenberg	Buy → Hold
May-09-22	Downgrade	Wolfe Research	Outperform → Peer Perform
Jan-10-22	Resumed	Citigroup	Buy
Dec-14-21	Downgrade	Redburn	Buy → Neutral
Dec-06-21	Downgrade	Exane BNP Paribas	Outperform → Neutral
Dec-03-21	Downgrade	Bryan Garnier	Buy → Neutral
Sep-20-21	Downgrade	Deutsche Bank	Hold → Sell

Show Previous Ratings

Jul-25-24 04:19AM	Dren Bio and Novartis link on bispecific antibodies for cancer (Pharmaceutical Technology)
Jul-24-24 07:24AM	Novartis invests in bispecifics for cancer; Bob Langer steps down from Moderna board (BioPharma Dive)
Jul-19-24 07:47AM	Lilly alone in bidding for Morphic; Novartis wont yet file MorphoSys drug (BioPharma Dive)
Jul-18-24 06:57PM	Novartis expects 'strong momentum' going into second half, says CEO Vasant Narasimhan (CNBC TV)
05:04PM	Health Care Roundup: Market Talk (The Wall Street Journal)
04:45PM	Loading…
04:45PM	Novartis Ag (NVS) Q2 2024 Earnings Call Transcript (Motley Fool)
04:15PM	Novartis Dives After Handing Amgen, Bristol And Their Rivals A Key Victory (Investor's Business Daily)
02:15PM	Why Novartis Stock Is Down Today Despite Topping Q2 Estimates (Motley Fool)
12:36PM	Analyst Report: Novartis AG (Morningstar Research)
10:15AM	Novartis Falls Despite Earnings Beat, Guidance Raise (Investopedia)
09:54AM	Novartis raises 2024 profit guidance, stock slipping though (Yahoo Finance Video)
09:30AM	Novartis (NVS) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
09:06AM	Novartis' Q2 Earnings: Revenue And EPS Beat, Raises 2024 Profit Forecast On Strong Demand For Key Drugs (Benzinga)
08:22AM	Novartis (NVS) Tops on Q2 Earnings, Ups Operating Income View (Zacks)
08:08AM	5 Things to Know Before the Stock Market Opens (Investopedia)
07:55AM	Loading…
07:55AM	Novartis Reports Nearly 40% Margin In Q2; Shares Slide (Investor's Business Daily)
07:55AM	Novartis Reports Near 40% Margin In Q2; Shares Slide (Investor's Business Daily)
06:53AM	Novartis reports 43% increase in net income in Q2 2024 (Pharmaceutical Technology)
06:05AM	Alnylam Stock Is a Blockbuster Biopharma In the Making (InvestorPlace)
05:13AM	Novartis: Q2 Earnings Snapshot (Associated Press Finance)
04:59AM	2 Magnificent Stocks to Buy With $500 (Motley Fool)
03:35AM	TSMC and Netflix rise premarket; Domino's Pizza, Beyond Meat fall (Investing.com)
02:23AM	Novartis raises FY profit guidance after strong quarter (Investing.com)
01:52AM	Novartis Raises Profit Guidance as Key Drugs Boost Sales (The Wall Street Journal)
01:00AM	Novartis continues to deliver strong sales growth and core margin expansion in Q2; raises FY 2024 bottom-line guidance (GlobeNewswire)
Jul-16-24 07:34AM	3 Global Stocks to Buy to Escape the Volatility on Wall Street (InvestorPlace)
02:35AM	Here's Why Aristotle Capital's International Equity Composite Sold Novartis AG (NVS) (Insider Monkey)
Jul-15-24 12:31PM	3 Spinoff Stocks You Should Buy Now: July 2024 (InvestorPlace)
09:40AM	Here's Why Novartis (NVS) is a Strong Value Stock (Zacks)
03:32AM	Goldman and Bank of America Earnings, ECB Rate Decision: What to Watch This Week (The Wall Street Journal)
07:00AM	Loading…
Jul-14-24 07:00AM	What To Expect in the Markets This Week (Investopedia)
Jul-13-24 11:00AM	The 7 Most Undervalued Healthcare Stocks to Buy in July 2024 (InvestorPlace)
06:26AM	3 Healthcare Stocks Injecting AI for Big Gains (InvestorPlace)
Jul-12-24 07:00AM	Leqembi sales inch higher; Sparks pivot leads to layoffs (BioPharma Dive)
06:15AM	The 3 Most Undervalued Pharma Stocks to Buy in July 2024 (InvestorPlace)
Jul-11-24 09:18AM	Novartis closes technical R&D site in San Diego as part of ongoing restructure (FierceBiotech.com)
Jul-09-24 11:17AM	What The Quest For New Cholesterol Treatments Means For Novartis, Merck And Patients (Investor's Business Daily)
Jul-08-24 11:53AM	UK pharma group reprimands Novo Nordisk for undisclosed payments (Pharmaceutical Technology)
03:00AM	Novartis Stock Generating Improved Relative Strength (Investor's Business Daily)
Jul-04-24 12:00PM	Upcoming Stock Spinoffs: Should You Pounce or Pass? (InvestorPlace)
Jun-26-24 03:12AM	Pharma M&A: The top high value deals in 2023 (Pharmaceutical Technology)
Jun-25-24 01:47PM	Novartis Stock Just Below Innovative Drugmaker's All-Time High; Gets Key Rating Upgrade (Investor's Business Daily)
08:13AM	ASCO24: Novartis Scemblix outperforms standard of care in CML (Pharmaceutical Technology)
Jun-24-24 09:40AM	Here's Why Novartis (NVS) is a Strong Value Stock (Zacks)
08:13AM	Does Legend Biotech (LEGN) Have a Long Runway for Growth? (Insider Monkey)
Jun-21-24 07:00AM	Jazz drug for tremor fails study; Radiopharma drug developer ITM swaps CEOs (BioPharma Dive)
Jun-20-24 09:50AM	Here's Why Novartis (NVS) is a Strong Momentum Stock (Zacks)
Jun-17-24 03:27PM	7 Breakthrough Biotech Stocks for a Shot of Portfolio Adrenaline (InvestorPlace)
Jun-16-24 08:12PM	EHA 2024: Novartis Scemblix takes on all TKIs in head-to-head CML trial (Clinical Trials Arena)
Jun-12-24 06:00AM	3 Crazy Good Stocks to Buy With $500 Right Now (InvestorPlace)
Jun-11-24 12:54PM	Is Novartis AG (NYSE:NVS) Investors Favorite International Dividend Stock? (Insider Monkey)
11:04AM	12 Best International Dividend Stocks to Buy Now (Insider Monkey)
08:37AM	30 Wealthiest People in Germany (Insider Monkey)
Jun-06-24 09:40AM	Why Novartis (NVS) is a Top Value Stock for the Long-Term (Zacks)
04:00AM	Germanys ITM raises $205M as radiopharma field booms (BioPharma Dive)
Jun-04-24 02:18PM	The 3 Most Undervalued Healthcare Stocks to Buy in June 2024 (InvestorPlace)
09:50AM	Why Novartis (NVS) is a Top Momentum Stock for the Long-Term (Zacks)
May-31-24 01:02PM	Novartis (NVS) Reports Positive Long-Term Data on CSU Drug (Zacks)
12:38PM	Novartis CEO: Our leukemia drug Scemblix is a potential $3 billion plus medicine (CNBC TV)
12:18PM	15 Most Profitable Biotechnology Companies in the World (Insider Monkey)
08:00AM	Novartis Scemblix® Phase III data first to show superior efficacy with a favorable safety and tolerability profile vs. standard-of-care TKIs in adults with newly diagnosed CML (GlobeNewswire)
06:55AM	Novartis reports Phase III data for trials of remibrutinib to treat CSU (Clinical Trials Arena)
04:00AM	Novartis study points to larger role for targeted leukemia drug (BioPharma Dive)
May-30-24 06:01PM	Novartis Phase III data confirm sustained efficacy and long-term safety of oral remibrutinib in chronic spontaneous urticaria (GlobeNewswire)
May-28-24 06:50AM	Roches Sabry retires; Duchenne drug fails confirmatory test (BioPharma Dive)
04:35AM	Novartis and Clarius partner for psoriatic arthritis care in Canada (Medical Device Network)
May-27-24 12:29PM	Novartis (NVS) Presents Positive Data on Renal Drugs at ERA (Zacks)
04:25AM	Dr. Reddys and Novartis sign distribution agreement for anti-diabetes products (Pharmaceutical Technology)
04:25AM	Novartis atrasentan shows to reduce proteinuria in Phase III IgAN trial (Clinical Trials Arena)
May-25-24 11:10PM	20 Biggest Publicly Traded Biotech Companies (Insider Monkey)
06:15AM	Novartis atrasentan Phase III data show clinically meaningful proteinuria reduction further advancing company's IgA nephropathy (IgAN) portfolio (PR Newswire)
06:00AM	Novartis presents latest Phase III Fabhalta (iptacopan) data in C3 glomerulopathy (C3G) showing clinically meaningful and statistically significant 35.1% proteinuria reduction vs. placebo (PR Newswire)
May-23-24 05:21PM	Meta, T-Mobile and Disney Boosted US Dividend Growth in First Quarter (Investopedia)
May-22-24 05:17PM	Top 20 Largest Publicly Traded Healthcare Companies (Insider Monkey)
04:56AM	Latest 340B ruling delivers blow to providers (Healthcare Dive)
May-17-24 05:51AM	Erasca restructures; Novartis moves to complete MorphoSys deal (BioPharma Dive)
May-16-24 01:00PM	Motor Neuron Disease Clinical Trial Pipeline Appears Robust With 120+ Key Pharma Companies Actively Working in the Therapeutics Segment DelveInsight (GlobeNewswire)
07:15AM	7 Pharma Stocks Harnessing AI Brainpower for Big Breakthroughs (InvestorPlace)
06:15AM	Patent Peril: 3 Stocks at Risk From the FTC's Drug Crusade (InvestorPlace)
05:27AM	Novartis meets all tender offer conditions to acquire MorphoSys AG for EUR 68 per share in cash (GlobeNewswire)
May-15-24 10:00AM	Novartis highlights pioneering innovation in CML with data from Scemblix® Phase III ASC4FIRST study in newly diagnosed patients at ASCO and EHA (GlobeNewswire)
08:19AM	Legend Biotech Corporation (NASDAQ:LEGN) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-14-24 06:30AM	3 Magnificent Stocks That Are Passive Income Machines (Motley Fool)
12:20AM	Q1 2024 Legend Biotech Corp Earnings Call (Thomson Reuters StreetEvents)
May-11-24 09:46AM	The 3 Best Mutual Funds to Buy in May 2024 (InvestorPlace)
May-10-24 06:30AM	3 Biotech Stocks to Sell in May Before They Crash & Burn (InvestorPlace)
May-08-24 03:15PM	Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-07-24 07:00AM	Arvinas Reports First Quarter 2024 Financial Results and Provides Corporate Update (GlobeNewswire)
May-05-24 02:25PM	2 Magnificent Dividend Stocks to Hold for the Next Decade (Motley Fool)
May-03-24 04:06PM	Bausch + Lomb Corporation (NYSE:BLCO) Q1 2024 Earnings Call Transcript (Insider Monkey)
01:08PM	Appian Corporation (NASDAQ:APPN) Q1 2024 Earnings Call Transcript (Insider Monkey)
12:36PM	Lantheus Holdings, Inc. (NASDAQ:LNTH) Q1 2024 Earnings Call Transcript (Insider Monkey)
08:15AM	Why selling to Novartis made sense for Mariana (BioPharma Dive)
May-02-24 03:58PM	Sector Update: Health Care Stocks Softer Late Afternoon (MT Newswires)
01:59PM	Sector Update: Health Care Stocks Retreat Thursday Afternoon (MT Newswires)
11:54AM	Top Midday Stories: Novo Nordisk, Linde Shares Fall Post-Earnings; Peloton Shares Plummet After Announcing Job Cuts, CEO Change; Exxon-Pioneer Deal Gets FTC Approval With One Caveat (MT Newswires)
10:30AM	Update: Novartis AG to Acquire Mariana Oncology in Deal Valued Up to $1.75 Billion. (MT Newswires)
08:20AM	Novartis to buy Mariana Oncology in radiopharmaceutical expansion (BioPharma Dive)
07:36AM	Novartis AG to Acquire Mariana Oncology (MT Newswires)
07:30AM	UPDATE 2-Novartis to buy radiology drug specialist Mariana for $1 billion (Reuters)

Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment includes researching, distributing and selling patented pharmaceuticals. The Sandoz segment focuses on marketing finished dosage form medicines and intermediary products including active pharmaceutical ingredients. The Corporate segment is involved in group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

NVS

Novartis AG ADR

Upgrade your FINVIZ experience